Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 278,893 | 266,586 | 441,702 | 286,749 | 459,277 |
| Marketable Securities | 713,698 | 701,039 | 563,748 | 835,934 | 753,706 |
| Receivables | 1,236 | 27,584 | 369 | 6,287 | 705 |
| Inventories | 29,184 | 35,589 | 30,933 | 23,903 | 23,548 |
| TOTAL | $1,242,004 | $1,249,874 | $1,218,792 | $1,283,918 | $1,350,037 |
| Non-Current Assets | |||||
| PPE Net | 111,403 | 106,381 | 98,810 | 99,288 | 104,031 |
| Investments And Advances | 0 | 0 | 545 | 0 | 376 |
| Intangibles | 0 | 2,137 | 2,082 | 0 | 2,507 |
| Other Non-Current Assets | 359,541 | 331,522 | 295,420 | 286,948 | 278,874 |
| TOTAL | $470,944 | $440,040 | $396,857 | $386,236 | $385,788 |
| Total Assets | $1,712,948 | $1,689,914 | $1,615,649 | $1,670,154 | $1,735,825 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 142,873 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 249,638 | 214,197 | 174,953 | 204,774 | 191,770 |
| Other current liabilities | 23,579 | 33,829 | 40,070 | 47,406 | 63,715 |
| TOTAL | $433,572 | $265,482 | $234,373 | $277,645 | $270,894 |
| Non-Current Liabilities | |||||
| Long Term Debt | 171,930 | 310,264 | 305,745 | 301,196 | 296,623 |
| Other Non-Current Liabilities | 96,186 | 78,629 | 57,782 | 50,767 | 52,201 |
| TOTAL | $268,116 | $388,893 | $363,527 | $351,963 | $348,824 |
| Total Liabilities | $701,688 | $654,375 | $597,900 | $629,608 | $619,718 |
| Shareholders' Equity | |||||
| Common Shares | 37 | 37 | 37 | 37 | 37 |
| Retained earnings | 1,011,223 | 1,035,502 | 1,017,712 | 1,040,509 | 1,116,070 |
| TOTAL | $1,011,260 | $1,035,539 | $1,017,749 | $1,040,546 | $1,116,107 |
| Total Liabilities And Equity | $1,712,948 | $1,689,914 | $1,615,649 | $1,670,154 | $1,735,825 |